CCEP vs KVUE
CCEP: A major beverages bottler and distributor serving Europe, Middle East, Africa, and Asia-Pacific markets through production and sale of Coca-Cola brands and other drinks. KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories.
Side-by-side fundamentals
| Metric | CCEP | KVUE | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $105.09 | $19.18 | |
| Market cap as of 2026-07-10 | $46.3B | $36.8B | |
| P/E as of 2026-07-10 | 20.89 | 22.70 | CCEP lower |
| PEG as of 2026-07-10 | 2.11 | 2.72 | CCEP lower |
| Net margin as of 2026-07-10 | +9.4% | +10.6% | KVUE higher |
| Gross margin as of 2026-07-10 | +36.3% | +58.9% | KVUE higher |
| Operating margin as of 2026-07-10 | +12.7% | +17.1% | KVUE higher |
| ROE as of 2026-07-10 | +24.5% | +15.2% | CCEP higher |
| ROA as of 2026-07-10 | +6.3% | +6.0% | CCEP higher |
| Debt / equity as of 2026-07-10 | 1.36 | 0.82 | KVUE lower |
| Revenue growth (YoY) as of 2026-07-10 | +11.7% | -0.1% | CCEP higher |
| Revenue CAGR (3y) SEC XBRL | n/a | +0.2% | |
| Dividend yield as of 2026-07-10 | +2.3% | +4.3% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | n/a | 3 | |
| Beta as of 2026-07-10 | 0.50 | 0.45 | |
| 1-year return as of 2026-07-09 close | +9.6% | -6.8% | CCEP higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.